Our findings highlight the role of FBLN1+ FRCs in fostering immune activation within the TME of HPV-associated OPSCC. Enhanced antigen presentation and epithelial proliferation likely facilitate tumor-immune interactions, contributing to better clinical outcomes. This study advances the understanding of TME dynamics in OPSCC and may inform future therapeutic strategies.
Gu et al. (Tue,) studied this question.